Molecular Metabolism, 2022 Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism Ho M., Zhang C., Moon I. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma | | | | |
Journal of Cardiovascular Translational Research, 2022 Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome Christersson C., Baron T., Flachskampf F. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
iScience, 2022 Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19 Buyukozkan M., Alvarez-Mulett S., Racanelli A. et al. Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum | | | | |
Brain and Spine, 2022 Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study Wichmann T., Kasch H., Dyrskog S. et al. Olink Target 96NeurologyPathophysiologyPlasmaCSF | | | | |
Journal of Neuroendocrinology, 2022 Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors Thiis‐Evensen E., Kjellman M., Knigge U. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
International Journal of Cardiology, 2022 Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study) de Lange I., Petersen T., de Bakker M. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Brain Communications, 2022 Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment Kivisäkk P., Magdamo C., Trombetta B. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Scientific Reports, 2022 Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis Pallares Robles A., ten Cate V., Schulz A. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Nature Biotechnology, 2022 Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR Schwarz M., Torre D., Lozano-Ojalvo D. et al. Olink Target 48Infectious DiseasesTechnical EvaluationPlasma | | | | |
Molecular Psychiatry, 2022 Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study Sandberg J., Hansson C., Göteson A. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
British Journal of Haematology, 2022 A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease Pratta M., Paczesny S., Socie G. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Scientific Reports, 2022 Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study Dlamini S., Norris S., Mendham A. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
European Journal of Endocrinology, 2022 Novel inflammatory biomarkers in thyroid eye disease Ueland H., Ueland G., Løvås K. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
Arthritis & Rheumatology, 2022 Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel Loza M., Nagpal S., Cole S. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Nature Communications, 2022 Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis Damsky W., Wang A., Kim D. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Communications Biology, 2022 Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort Yang J., Jia Z., Song X. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma | | | | |
Frontiers in Neurology, 2022 Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease Carlyle B., Kitchen R., Mattingly Z. et al. Olink Target 96NeurologyTechnical EvaluationPlasma | | | | |
Nature Medicine, 2022 Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial Padrón L., Maurer D., O’Hara M. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
BMC Women's Health, 2022 Applicability of polygenic risk scores in endometriosis clinical presentation Svensson A., Garcia-Etxebarria K., Åkesson A. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
Brain, 2022 A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease Bottigliengo D., Foco L., Seibler P. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |